Bevacizumab (Avastin) is an inhibitor of the VEGF that is used in diabetic macular edema (DME), age- related macular degeneration (ARMD) and cystoid macular edema (CMO) intravitreally. The gene discussed is VEGFA; the disease is age-related macular degeneration.